Filter announcements
Loading...
Founded in June 1998, Quest Laboratories Limited produces a diverse range of pharmaceuticals, including antibiotics, antimalarials, anti-inflammatories, etc.
Here's a summary of the attached investor presentation: **1. Financial Highlights:** Quest Laboratories reported strong Q1 FY26 YoY growth: Revenue rose 52% to ₹23.18 Cr, and both EBITDA and PAT saw significant jumps. FY25 revenue topped ₹100 Cr. However, operating cash flow for FY25 was negative, affected by working capital....
1. Financial Highlights: Quest Laboratories reported revenue of ₹103.92 Cr, up 25.9% YoY. EBITDA rose modestly by 2.7% to ₹15.98 Cr, with margins contracting to 15.4% from 18.9%. Profit after tax increased 34.4% to ₹13.57 Cr, with PAT margins expanding to 13.1%. Gross profit margin declined sharply to 23.8% from...
**Financial Highlights:** Quest Laboratories reported revenue of ₹42.63 crore for H1 FY25, up from ₹41.02 crore in H1 FY24, with EBITDA growing 29.13% to ₹12.19 crore and PAT increasing by 26.74% to ₹8.01 crore. EBITDA margin improved to 28.07%, up 508.66 basis points, reflecting enhanced operational efficiency. **Strategic Initiatives and...